Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2013
An abnormal apelin/vasopressin balance may contribute to water retention in patients with the syndrome of inappropriate antidiuretic hormone (SIADH) and heart failureAnne Blanchard, Olivier Steichen, Nadia De Mota, et al.The Canadian Journal of Cardiology|January 29, 2022
QGC606: A Best-in-Class Orally Active Centrally Acting Aminopeptidase A Inhibitor Prodrug for Treating Heart Failure Following Myocardial InfarctionSolène E Boitard, Mathilde Keck, Robin Deloux, et al.Proceedings of the National Academy of Sciences of the United States of America|July 3, 2004
Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin releaseNadia De Mota, Annabelle Reaux-Le Goazigo, Said El Messari, et al.Journal of Hypertension|March 19, 2019
A pilot double-blind randomized placebo-controlled crossover pharmacodynamic study of the centrally active aminopeptidase A inhibitor, firibastat, in hypertensionMichel Azizi, Pierre-Yves Courand, Thierry Denolle, et al.Nature Communications|January 13, 2021
A metabolically stable apelin-17 analog decreases AVP-induced antidiuresis and improves hyponatremiaAdrien Flahault, Pierre-Emmanuel Girault-Sotias, Mathilde Keck, et al.Plos One|February 8, 2014
Mechanisms involved in dual vasopressin/apelin neuron dysfunction during agingJulie Sauvant, Jean-Christophe Delpech, Karine Palin, et al.The Canadian Journal of Cardiology|December 14, 2024
The Metabolically Resistant Apelin-17 Analogue LIT01-196 Reduces Cardiac Dysfunction and Remodelling in Heart Failure After Myocardial InfarctionPierre-Emmanuel Girault-Sotias, Robin Deloux, Nadia De Mota, et al.The Journal of Clinical Endocrinology and Metabolism|March 12, 2016
Plasma Apelin Concentrations in Patients With Polyuria-Polydipsia SyndromeSandrine Andrea Urwyler, Katharina Timper, Wiebke Fenske, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 31, 2009
Identification and pharmacological properties of E339-3D6, the first nonpeptidic apelin receptor agonistXavier Iturrioz, Rodrigo Alvear-Perez, Nadia De Mota, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 6, 2016
Development of original metabolically stable apelin-17 analogs with diuretic and cardiovascular effectsRomain Gerbier, Rodrigo Alvear-Perez, Jean-Francois Margathe, et al.Pageof 2